FDA Approves Tecvayli Plus Darzalex Faspro for Relapsed or Refractory Multiple Myelomanuaxia30 jul0 min de lecturaObtuvo NaN de 5 estrellas.
PTC Therapeutics wins auction for Sangamo’s ST-920 Fabry gene therapy in deal worth up to $211 million
Health Canada licenses Light AI’s QuickScan Strep A smartphone software for suspected strep throat assessment
Comentarios